🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| 14/12/2022 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/10/2010 | 35,37 | 35,45 | 35,26 | 35,40 | +0,00% | 0,54% | 6.634.469 |
| 21/10/2010 | 35,40 | 35,45 | 34,90 | 35,40 | +0,30% | 1,54% | 10.870.904 |
| 20/10/2010 | 34,93 | 35,54 | 34,90 | 35,30 | +1,29% | 1,86% | 10.133.426 |
| 19/10/2010 | 35,31 | 35,35 | 34,65 | 34,85 | -1,91% | 2,00% | 10.869.961 |
| 18/10/2010 | 35,22 | 35,53 | 35,22 | 35,52 | +0,76% | 0,89% | 11.109.953 |
| 15/10/2010 | 35,56 | 35,73 | 35,08 | 35,26 | -0,54% | 1,82% | 15.746.619 |
| 14/10/2010 | 35,56 | 35,67 | 35,15 | 35,45 | -0,03% | 1,45% | 10.002.531 |
| 13/10/2010 | 35,17 | 35,68 | 35,10 | 35,46 | +1,42% | 1,66% | 10.230.890 |
| 12/10/2010 | 34,99 | 35,13 | 34,66 | 34,96 | -0,60% | 1,36% | 11.570.339 |
| 11/10/2010 | 35,17 | 35,31 | 34,99 | 35,17 | -0,14% | 0,90% | 5.843.858 |
| 08/10/2010 | 35,13 | 35,30 | 34,93 | 35,22 | +0,54% | 1,03% | 9.097.478 |
| 07/10/2010 | 35,64 | 35,68 | 34,95 | 35,03 | -0,81% | 2,03% | 14.564.894 |
| 06/10/2010 | 35,34 | 35,52 | 35,13 | 35,31 | -0,03% | 1,08% | 7.903.282 |
| 05/10/2010 | 35,17 | 35,45 | 35,02 | 35,32 | +1,37% | 1,22% | 11.181.322 |
| 04/10/2010 | 34,82 | 35,07 | 34,63 | 34,85 | -0,22% | 1,26% | 9.678.175 |
| 01/10/2010 | 35,08 | 35,15 | 34,69 | 34,92 | -0,57% | 1,33% | 12.305.511 |
| 30/09/2010 | 35,51 | 35,86 | 34,96 | 35,12 | -0,84% | 2,53% | 14.353.408 |
| 29/09/2010 | 35,40 | 35,55 | 35,17 | 35,42 | -0,35% | 1,08% | 9.904.858 |
| 28/09/2010 | 35,58 | 35,76 | 35,32 | 35,54 | +0,32% | 1,23% | 13.333.285 |
| 27/09/2010 | 35,70 | 35,76 | 35,43 | 35,43 | -0,56% | 0,94% | 11.592.766 |
| 24/09/2010 | 35,13 | 35,68 | 35,05 | 35,63 | +1,86% | 1,79% | 12.195.052 |
| 23/09/2010 | 34,99 | 35,30 | 34,85 | 34,98 | -0,81% | 1,28% | 11.111.525 |
| 22/09/2010 | 35,03 | 35,35 | 34,95 | 35,27 | +0,65% | 1,14% | 12.992.790 |
| 21/09/2010 | 34,87 | 35,25 | 34,70 | 35,04 | +0,49% | 1,56% | 12.841.039 |
| 20/09/2010 | 34,69 | 34,96 | 34,57 | 34,87 | +0,58% | 1,13% | 11.028.942 |
| 17/09/2010 | 34,83 | 35,15 | 34,50 | 34,67 | -0,27% | 1,86% | 17.186.571 |
| 16/09/2010 | 34,82 | 34,93 | 34,54 | 34,76 | -0,22% | 1,12% | 9.526.006 |
| 15/09/2010 | 34,85 | 35,18 | 34,58 | 34,84 | -0,03% | 1,72% | 12.042.882 |
| 14/09/2010 | 34,45 | 35,02 | 34,41 | 34,85 | +0,83% | 1,77% | 13.468.058 |
| 13/09/2010 | 34,94 | 34,94 | 34,35 | 34,56 | -1,17% | 1,69% | 11.453.173 |